Efficacy of individualized homeopathy as an adjunct to standard of care of COVID-19: A randomized, single-blind, placebo-controlled study

Abstract

• A randomized, placebo-controlled trial of adjunct homeopathy with standard of care for COVID-19 was conducted on 300 patients. • Primary outcome on total symptom score measured over 10 days decreased significantly favoring Standard of care + Homeopathy. • Recovery was earlier in Standard of care + Homeopathy group by 02 days showing the added benefits of homeopathy. • Resolution of fever was 20 h earlier in Standard of care + Homeopathy. • Arsenicum album , Bryonia alba and Phosphorus were the most frequently prescribed medicines.